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understand cellular events in living organisms. In this review, we focus on protein complementation
assays (PCAs) that have been developed to detect in vivo protein interactions as well as their mod-
ulation or spatial and temporal changes. The uses of PCAs are increasing, spanning different areas
such as the study of biochemical networks, screening for protein inhibitors and determination of
drug effects. Emphasis is given to approaches that rely on signals of spectroscopic nature (i.e. ﬂuo-
rescence or luminescence), the ones that are more directly related to bioimaging.
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The protein sequence universe is expanding at vertiginous
speed as a result of decoding the genomes of many divergent
organisms. One of the follow-ups of whole-genome sequencing
projects consists in deciphering how this myriad of proteins inter-
acts with each other. Proteins display high connectivity in the cell.
In other words, proteins never act alone; on the contrary, they
associate with other proteins to form stable or transient multipro-
tein complexes that execute a deﬁned function. Importantly, aber-
rant protein interactions are related to many diseases and
therefore, they have become important targets for the develop-
ment of new chemical drugs. Overall, there is a requirement of
techniques that allow studying protein binding as well as their
speciﬁc inhibition in vivo because the cellular environment highly
affects the establishment of these interactions.
Protein-fragment complementation assays (PCAs) might fulﬁl
the above-mentioned needs because they are particularly wellchemical Societies. Published by E
plementation; PCA, protein-
cent protein; FP, ﬂuorescent
in–protein interaction; RET,
sonance energy transfer; FC,
by mass spectrometry; Y2H,
tura), FrancescXavier.Aviles@suited to detect protein interactions in the cell. They are based in
the fusion of the hypothetical binding partners to two rationally
designed fragments of a reporter protein [1]. The interaction
between bait and prey proteins brings the split reporter frag-
ments close enough to enable their non-covalent and speciﬁc
reassembly followed by the recovery of its native structure and
activity.
Different types of proteins have been used as protein reporters:
dihydrofolate reductase (DHFR) [2], b-lactamase [3], TEV protease
[4], green ﬂuorescent protein (GFP) or its variants [5], luciferase
[6], etc. Accordingly, the signal readout can be colour, cell survival
or ﬂuorescence, among others. PCAs were originally developed
with DHFR, but the availability of ﬂuorescent or luminescent pro-
teins has signiﬁcantly extended their applicability. DHFR enables
the use of two different signals to report on protein binding: cell
survival (using methotrexate, a DHFR inhibitor) or ﬂuorescence
(in the presence of a ﬂuorescent substrate) [6]. On the other hand,
if ﬂuorescent [7] or luminescent proteins [8–10] are used, the
signal is of spectroscopic nature. Particularly, when the reporter
proteins are ﬂuorescent proteins (FPs), we speak about bimolecular
ﬂuorescence complementation (BIFC).
Up to now, PCAs have been used in the study of in vivo protein–
protein interactions (PPIs) at different levels: from the study of
speciﬁc bindings in vivo to the screening of novel PPIs in different
organisms, ranging from bacteria to animals or plants. Moreover, it
has been demonstrated that BIFC is a very sensitive method that
can be applied to measure spatial and temporal changes in protein
complexes in response to drugs that activate or inhibit particularlsevier B.V. All rights reserved.
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in protein–protein binding [11].
2. Fundamentals
The PCAs are based on the formation of a bimolecular complex
when two non-active fragments of a reporter protein are brought
together due to an interaction between bait and prey (where both
are fused to the split domains of the reporter) (Fig. 1). The process
starts with the interaction of the bait and prey proteins (complex
1). Importantly, this binding occurs in competition with alternative
endogenous interaction partners present in the cell (complex 2).
The interaction brings the two split fragments in proximity
enabling their non-covalent reassembly, folding and recovery of
protein reporter function.
The folding and activity of the protein reporter depends com-
pletely on the interaction between prey and bait. What’s more, in
the case of BIFC, the ﬂuorescence signal qualitatively correlates
with the interaction strength [12]. Thus, mutations that affect the
binding interface cause a decrease in ﬂuorescence emission. There-
fore, BIFC can be used to map interaction surfaces in protein
complexes.
A crucial requirement for the method is that the dissected frag-
ments should not associate spontaneously in the absence of the
binding proteins because this would render the method useless
due to the presence of false positives. Studying the self-assembly
of FPs, it has been concluded that, if they are expressed at high lev-
els, in certain cases, the fragments can self-associate with each
other regardless of the PPI [13]. This tendency depends on the frag-
ments, the proteins fused to them and the cellular environment.
Thus, it is really important to perform appropriate controls in PCAs
to ensure the speciﬁcity of the detected signal. Also, to avoid self-
association, it is advisable to express the protein fusions at low
levels, close to those of the endogenous counterparts, if possible.Fig. 1. Pathway for protein complementation assays (PCAs) complex formation. In PCAs
protein (N-terminal fragment, NRP and C-terminal fragment, CPR) and both fusions are co
domains of the reporter together enabling its reassembly and recovery of its activity.
alternative endogenous interaction partners present in the cell (complex 2).3. Strategy design
The particular design of the PCA experiment might strongly
determine its results. Different aspects have to be taken into
account:
3.1. Protein reporter
The selection of the protein reporter will depend on the goal of
the study and the bait protein. The Table 1 summarizes the differ-
ent enzymes that have been used. Particularly, DHFR has been
widely used in experiments involving library selections, whereas
FPs or luminescent proteins are more suitable for studying a spe-
ciﬁc protein interaction: location, dynamics, inhibition or surface
mapping. The simplest reporters are FPs because the readout is di-
rectly provided by the protein ﬂuorophore and there is no need of
any substrate (as in the case of luminescent proteins or DHFR). One
important feature to consider when using FPs as reporters is that
their reassembly is usually irreversible [12,14,15]. However, sev-
eral studies suggest that the bimolecular complex can be partially
reversible [16–18]. Nevertheless, in those cases, it has not been
demonstrated convincingly that the signal fading is linked to a dis-
sociation of the fusion proteins. Besides, during in vivo experi-
ments, other possibilities such as proteosomal degradation
cannot be excluded [19]. On the other hand, one cannot disregard
that BIFC provide a stable ﬂuorescence signal that is especially use-
ful when working with weak or transient PPIs.
3.2. Protein reporter fragments
The fragmentation pattern for the chosen protein reporter is
usually well deﬁned [5]. Each protein requires speciﬁc breaking
points that allow the non-covalent protein reconstitution while
minimizing the spontaneous folding.each interaction partner (bait, X and prey, Y) is fused to a fragment of the reporter
-expressed in the cell. The binding between X and Y (complex 1) brings the two split
It has to be taken into account that this process occurs in competition with the
Table 1
Proteins used in the protein-fragment complementation assays.
Reporter protein Readout Application Organism References
Detection of PPIs
(protein–protein
interactions)
Localization
of PPIs
Dynamics Lysate Bacterial
cells
Mammalian
cells
Living
animals
b-lactamase Fluorescence, absorbance U  Limited U U U  [50]
b-galactosidase Fluorescence, absorbance U   U U U  [51]
Dihydrofolate reductase (DHFR) Fluorescence, cell survival U U    U  [32,34]
Fluorescent proteins (FPs) Fluorescence U U Limited U U U  [52]
Ubiquitin Reporter-gene activation U     U U [53]
Luminescent proteins Bioluminscence U Limited U U U U U [54]
TEV protease Reporter-gene activation U     U  [4]
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Usually the linker is a sequence of serines and glycines that pro-
vides polarity and ﬂexibility to the protein fusion. The standard
length is around 10 amino acids but it could be shorter if the
bait/prey are short peptides to avoid entropic penalty upon binding
[12].
3.4. Topology of the protein fusions
Fusions constructs should be designed in order to minimize ste-
ric constraints in the reconstitution of the protein reporter. Gener-
ally, it is not possible to foresee the more optimal arrangement and
it should be empirically tested.
3.5. Expression system
Protein fusions need to be expressed at levels that allow detec-
tion of the regained function. However, it should be noted that high
expression levels might result in non-native interactions, complex
miss-localization or spontaneous reassembly of the protein repor-
ter fragments. Therefore, the use of endogenous promoters is
highly advisable.
3.6. Controls
It is important to design negative controls to ensure the
speciﬁcity of the detected signal. One possibility is to substitute
one of the partners with a non-binding polypeptide. Another one
is to introduce mutations that reduce or eliminate the interaction,
giving rise to a speciﬁc decrease or abolishment of the signal. Also,
the swapping of the reporter fragments may be used as a control.
In this case, no changes in the readout should be observed.
4. Detection and characterization of speciﬁc PPIs
In general, in order to study a speciﬁc protein interaction, ﬂuo-
rescent or luminescent proteins are chosen as reporters because
they enable an easy imaging of bindings in vivo.Table 2
Examples of protein interactions visualized using bimolecular ﬂuorescence complementat
Proteins
Adenosine and dopamine receptors [55], spliceosomal proteins [56], nucleosome bindin
Chaperones [25], SH3 domains [12], leucine zippers [14]
Stomatin-like proteins (SPL) related to locomotion [58], proteins related to DNA repair
Growth factors that regulate embryonic cell differentiation [60]
Proteins related to MicroRNA biogenesis [61], membrane proteins [62], transcription fac
related to leaf senescence [63]
Signaling proteins [16], cytoskeletal proteins [64], proteins involved in meiotic silencing4.1. Split ﬂuorescent proteins (BIFC assays)
FPs have been used to study binary interactions among a wide
range of proteins in many organisms (Table 2). In the ﬁrst pioneer-
ing works, strong binders were used as a proof of principle (i.e. leu-
cine zippers interactions). But the ability of this system to detect
weak interactions (around micromolar range) has also been con-
ﬁrmed [12,20]. This property is biologically relevant because the
majority of cellular interactions are weak. Moreover, it has been
shown that the ﬂuorescence signal correlates with the interaction
strength, allowing its application to map PPI surfaces by introduc-
ing site-directed or random mutations and analyzing the resulting
changes in ﬂuorescence [12].
BIFC assay also enables the visualization of multiple protein
interactions [21]. The multicolour BIFC exploits the ability of frag-
ments from different FPs to reassemble forming a protein with new
and different spectral characteristics. This fact enables to simulta-
neously visualize multiple protein complexes in a single cell [5,22]
and thus, to investigate the competition between mutually exclu-
sive interaction partners as well as to compare their intracellular
distributions [23] (Fig. 2).
On the other hand, BIFC-based resonance energy transfer (BIFC-
RET) has been recently created to image and identify ternary pro-
tein complexes [24]. There are two versions of this assay. First, a
ﬂuorophore reconstituted by BIFC can be an acceptor for RET (res-
onance energy transfer) from a bioluminescent protein in a process
of bioluminescence-RET. Alternatively, the reassembled FP can act
as either acceptor/donor for RET from/to another FP (leading to
ﬂuorescence-RET). In these assays, together with the two proteins
fused to the FP fragments, a third partner is linked to a ﬂuorescent/
luminescent protein. The binding between the two ﬁst proteins
reconstitutes the FP, which can act as a donor/acceptor to the other
reporter if the ternary complex is formed (Fig. 2).
Furthermore, BIFC can be used to detect the presence of com-
pounds that perturb protein binding, being able to distinguish
inhibitors with dissimilar potency [25]. One key issue in this appli-
cation is the practical irreversibility of the FP reassembly. As a re-
sult, the addition of competitors upon reconstitution does no effect
the ﬂuorescence emission preventing the detection of interactionion (BIFC) in different organisms.
Organism
g proteins [57] Mammalian cells culture
Bacteria (Escherichia coli)
[59] Nematode (Caenorhabditis elegans)
Amphibian (Xenopus laevis)
tors Plants (Arabidopsis thaliana, Nicotiana
benthamiana)
[65] Fungi (Saccharomyces cerevisiae, Neurospora
crassa)
Fig. 2. Bimolecular ﬂuorescence complementation (BIFC) application to study speciﬁc protein–protein interactions (PPIs). (A) Principle of the multicolour BIFC assay. Proteins
X and Z are fused to the N-terminal fragments of two different FPs (ﬂuorescent proteins) (cyan and yellow, respectively); and protein Y (a common binder of proteins X and Z)
is fused to the C-terminal fragment of the yellow FP. The complex between X and Y can be distinguished from complex Y–Z due to the differences between the ﬂuorescence
spectra of the reassembled FPs. (B) Assays for the visualization of ternary complexes using BIFC-based resonance energy transfer (BIFC-RET). One interaction partner is linked
to a FP (Cyan FP) and each of the other two partners, to a fragment of another FP (in this case, Yellow FP). If these last two proteins interact, the yellow FP reassembles and
recovers its 3D structure and activity. Then, if the ternary complex is formed, a ﬂuorescence-RET process occurs, where the cyan FP acts as a donor and the yellow FP, as
acceptor. In the BRET-BIFC assay, one interaction partner is fused to a luminescent protein (Renilla luciferase, Rluc) whereas the other two are linked to fragments of the
yellow FP. Under normal conditions Rluc oxidizes coelenterazine to colenteramide emitting light. If the three proteins interact forming a multiprotein complex, the
reassembled yellow FP can act as receptor of the light emitted by Rluc in a bioluminescent-RET phenomenon.
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ready present in the cell before the expression of the binding part-
ners. In fact, this circumstance turns to be helpful in the screening
of biologically relevant inhibitors: a pre-incubation step avoids the
selection of high afﬁnity compounds that cannot penetrate or be
stable enough in the cell.
4.2. Split luminescent proteins
Renilla and ﬁreﬂy luciferases have become the most widely used
luminescent reporters. A common feature of this type of enzymes
is that they need to process a substrate to generate biolumines-
cence. Thus, in contrast to BIFC, this compound has to be added
in the system in order to obtain a signal.
One of the main advantages of using luminescent proteins is
their reversible reassembly due to the presence of structurallyindependent sub-domains in the protein. Accordingly, the addition
of an inhibitor leads to the disruption of the bimolecular com-
plex with the concomitant signal disappearance. Therefore, PCAs
with bioluminescent proteins as reporters are specially suited for
the study of PPI dynamics [26,27]. The choice between ﬂuorescent
or bioluminescent proteins as reporters will depend on the
objective of the study and the characteristics of the target
interaction.5. PCAs applied to high-throughput requirements
Perhaps, one of the most exciting properties of PCAs is that they
can be easily implemented for the high-throughput a analysis of
PPIs in living cells, becoming a very useful tool for proteomic and
system biology studies, as we discuss in the next sections.
1688 M. Morell et al. / FEBS Letters 583 (2009) 1684–16915.1. Screening of interactions
PCAs can be used as screening tool to identify potential interac-
tion partners of a speciﬁc protein [28]. The bait protein fused to
one of the reporter fragments is screened against a cDNA library
fused to the complementary portion (Fig. 3). One recent develop-
ment to create the library of endogenous proteins is the use of a
retroviral mutagen vector that efﬁciently activates and tags host
genes. This approach applied in BIFC has been used to successfully
identify novel substrates and regulators of the serine/threonine
protein kinase PKB/Akt [29].
These experiments can be followed by a second step that en-
ables the functional validation of the detected PPIs. This is an
advantage because, regardless of the employed approach, the de-
tected bindings between bait and prey proteins are sometimes
only tentative. The interaction is conﬁrmed through the addition
of an agent that perturbs the biochemical network in which the
bait protein is known to be involved. Changes in PCA signal inten-
sity or localization allow to conﬁrm that a visualized PPI is not a
false positive or an artefact.
Proteomic experiments require high-throughput approaches
able to detect and analyse the generated signals in an automatedFig. 3. High-throughput application of protein-fragment complementation assays (PCAs)
using PCAs. The bait protein is fused to a fragment of the reporter protein (in this case, the
under preferably an endogenous promoter. Afterwards, employing for example a retrovir
to complementary protein fragment (CRP). Cells co-expressing an interaction pair could
genes can be sequenced and identiﬁed. (B) Strategy for inferring pathway organization
supposed to be involved in the pathway is screened against the other ones. The results are
green one corresponds to an interaction. All the positive hits are afterwards subjected to
microscopy. Second, the interactions are tested for responses to compounds that pertur
readout in all the interactions that compose that pathway. And an inhibitor (I) will decre
from these experiments enable to create a pharmacological proﬁle of each interaction aand fast manner. In this sense, the coupling between BIFC and ﬂow
cytometry (FC) is a sensitive way of measuring weak PPIs; at the
same time, it allows dealing with large libraries providing a fast
sample rate and a qualitative evaluation of the interaction
strength. Thus, BIFC–FC has found application in the screening of
mutations that modulate protein interaction afﬁnity and speciﬁcity
[30].
One special feature of PCAs is that they allow a library-versus-
library selection. This type of experiments is not so straightforward
employing another method and it is particularly useful in protein
design and to reveal structural/functional relationships. For exam-
ple, it was used in bacteria to screen two libraries for leucine zipper
forming peptides using DHFR as reporter [31].
On the other hand, PCAs have also been applied to a genome-
wide screening in Saccharomyces cerevisiae using DHFR as split re-
porter and cell growth as signal readout [32]. Particularly, it has
been employed a mutated version DHFR that it is not sensitive to
the inhibitor methotrexate. When this drug is added to growth
media, only the cells expressing an interaction pair will survive.
Particularly, 2770 interactions have been detected identifying
new binding pairs and discovering an unknown sub-space of the
yeast interactome.to study protein interactions. (A) Procedures of a screening for interaction partners
N-terminal fragment, NPR). In a host cell line, the protein fusion is stably expressed
al mutagen vector, the cells are induced to express also endogenous proteins linked
be isolated by FC due to their ﬂuorescence. After a cell sorting process, the target
using PCAs. First, all the interaction pairs are identiﬁed using PCAs: each protein
summarized in a matrix: a red square means a negative result (no interaction) and a
two different analyses. First, the subcellular locations of the PPIs are imaged using
b the network. For example, the addition of a stimulator (S) will increase the PCA
ase the signal in all the bindings situated downstream of its target. The data derived
nd even to deduce the pathway organization.
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If the bait protein is involved in cellular trafﬁcking or in a
speciﬁc metabolic route, PCAs could provide information to infer
the pathway organization or, additionally, to detect unknown con-
nections between different pathways [33]. First, a screening of PPIs
between proteins supposed to be involved in a speciﬁc pathway
needs to be performed. The results are then represented in a matrix
that summarizes the positive (binding) and negative (non-binding)
outcomes. The positives clones (i.e. cells expressing a interacting
pair) are selected for further analysis. Particularly, they are treated
with drugs known to target the studied pathway. The approach
allows to generate a pharmacological proﬁle that helps in the
understanding of the pathway organization (Fig. 3). A speciﬁc PPI
inhibitor will impinge on all the interactions situated downstream
the cascade without affecting the ones upstream of its point of ac-
tion. In addition, with a ﬂuorescent readout, changes in the locali-
zation of the interaction pair upon upstream drug action can also
be imaged. This strategy has been used to study a signal transduc-
tion pathway involved in the control of initiation of eukaryotic
translation as well as its linkage with another pathway controlled
by a kinase. Importantly, the data gave rise to a detailed represen-
tation of the pathway including both the PPIs and their response to
speciﬁc antagonists [34].
5.3. Identiﬁcation of drug effects
On the other way around, PCA can be used to undercover the
speciﬁc effect of pharmaceutical compounds by measuring the spa-
tial and temporal changes in protein complexes in response to
drugs that act over particular pathways.
A foundational study has been reported by MacDonald et al.
[35]. First, different PPI pairs were chosen as ‘sentinels’ of different
biochemical pathways (with a pharmacological interest or in-
volved in essential cellular functions) and fused to FP fragments.
The strategy is based in the above-mentioned principle that drugs
having an activity on another protein complex could also affect the
downstream BIFC labelled complex due to a cascade effect. Using
microscopy, changes in protein complexes were measured directly
in cells grown on micro plates. The signal was extracted using dif-
ferent algorithms that quantify variations in intensity or localiza-
tion of the ﬂuorescence. Finally, the effect of each drug on each
particular BIFC assay was subjected to hierarchical clustering.
The data allow inferring the mechanism of action of novel drugs
enabling a further optimization. Also, in principle, structure–func-
tion relationships could be established between conformationally
unrelated chemical compounds. Overall, this strategy promises to
be of great help to enhance the productivity of drug-discovery
research.
5.4. Screening of PPIs inhibitors
The potentiality of PCAs in the screening of compounds that
interfere with PPIs has been proved using as reporters b-galactosi-
dase [36] or FPs [19]. If an inhibitor of the target interaction is
present, the recorded signal decreases in correlation with its
inhibitory potency. For example, it has been applied in the deﬁni-
tion of the active site of a peptidic inhibitor [25] or in the identiﬁ-
cation of antagonist receptors in libraries of around 30000
compounds [37].
It has to be taken into account that the use of PCAs entails the
in vivo screening of biologically relevant antagonists. In the condi-
tions of the experiment, the compounds selected as good inhibitors
are the ones displaying a high afﬁnity for its target and high cell
penetrability and stability in the harsh cellular environment.6. Advantages and disadvantages of PCAs
PCAs have some features that are advantageous in comparison
with alternative and widespread techniques to detect and identify
PPIs. The use of FPs or other enzymes that can provide ﬂuorescence
as signal readout enables a direct detection of PPIs. Like PCAs, ﬂuo-
rescence-RET experiments also use ﬂuorescence emission as signal
[38] and have been successfully coupled to FC [39]. With the ﬂuo-
rescence-RET technique, complex dynamics can be also analyzed
due to the reversibility of the interaction between reporter pro-
teins. But, in contrast, it has lower sensitivity: the detection of
the signal can be difﬁcult due to background ﬂuorescence resulting
from direct acceptor excitation. This problem is avoided in PCAs
where the detection of enzymatic activity does not occur in the
absence of the interacting partners if the experiment is properly
designed [12].
Two important pros of PCAs are their applicability to high-
throughput experiments and their ability to work in vivo.
Therefore, the monitored PPIs are established in the endogenous
background. This is of basic importance because many interactions
are dependent on post-translational modiﬁcations or on the pres-
ence of additional partners. PCAs share with phage display technol-
ogy [40] its high-throughput sample rate as well as the ability to
distinguish between protein binders with different speciﬁcity
and/or afﬁnity. In comparison to PCAs, phage display technique
has important limitations like its difﬁcult application to weak
interactions and its in vitro context.
Like PCAs, yeast two-hybrid (Y2H) permits in vivo genome-
wide screening for weak PPIs [41], but the system requires the nu-
clear importation of the fusion proteins. In comparison, PCAs work
in all the cellular compartments tested so far. In addition, Y2H as-
says are limited to the study of binary interactions whereas PCAs
can be applied to study ternary protein complexes, the competition
for the binding to a speciﬁc protein or the subcellular localization
of PPIs.
Afﬁnity puriﬁcation followed by mass spectrometry (AP/MS)
[42] has been widely used to address PPI networks. In this ap-
proach, interactions take place in the cell but the need for cellular
disruption and stringent puriﬁcations steps might perturb native
complexes and preclude the detection of weak interactions. In a re-
cent paper, a comparative quality study of the yeast interactome
datasets obtained using various methods has been performed
[43]. It proposes that the Y2H (and to some extent, other methods
to detect binary interactions like PCAs) and AP/MS are essential
tools in the study of the interactome because the data obtained
from both approaches is complementary and fundamental for a
comprehensive representation of the PPI networks. In particular,
it is found that interactome datasets obtained by detecting binary
interactions are signiﬁcantly enriched in transient interactions.
7. Perspectives
The present review exempliﬁes how PCAs are increasingly being
adopted by the ‘interactomic’ community as standard methods to
detect and characterize PPIs in the cell. The approach is extremely
ﬂexible and, as a consequence, PCAs applications are spreading to
unsuspected areas of research such as the visualization of cellular
processes involving other biomolecules, such as interactions
between proteins and RNA [44,45] and likely, in a near future, to
the analysis of lipids or sugars [21].
An outcome of massive proteomic studies and the deciphering
of PPI networks is that both the traditional concept of one
protein/one function and the assumption that drugs are always
speciﬁc against a single protein target are not longer valid. The pro-
tein function is now considered in the context of systems biology
1690 M. Morell et al. / FEBS Letters 583 (2009) 1684–1691framework. It is clear that drugs can interact with more than one
target, disturb other cellular functions or cause feedback reactions
in the targeted pathway. The ability of PCAs to detect these
undesired side reactions is expected to become very useful in the
drug-discovery pipeline.
The establishment of PPIs is a dynamic phenomenon regulated
by the cellular environment. Most structural biology methods only
permit to capture a static view of the architecture of multiprotein
complexes. In the next future it is foreseen that the structural res-
olution of a multiprotein complex by experimental or computa-
tional approaches would be combined with PCA experiments
either to conﬁrm the new experimental structures or the homology
models [46].
Fortunately there is still much room to improve the character-
istics of PCAs. Particularly, it is important to improve some proper-
ties of FPs like their kinetics of folding or chromophore maturation
[47]. Another important aspect is to diminish the self-assembly
tendency of the protein fragments. Also, it has to be taken into
account that, for live-cell imaging in vivo , spectral variants with
long-wavelength ﬂuorescence emission have to be developed
[48]. Finally, improvements in the sensitivity and spatial resolution
of ﬂuorescence imaging will help to overcome the uncertainty of
the microscopy techniques [49].Acknowledgements
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